Detheux Michel
SEC insider (Form 3/4/5 filer). CIK 0001816196. Director at Vor Biopharma Inc. (VOR) and 1 other issuer. 34 reported Form 4/5 transactions since Sep 2024; latest on Jun 11, 2026. Located in BOSTON, MA.
Companies Detheux Michel has filed insider reports for
- Vor Biopharma Inc. (VOR): Director
- iTeos Therapeutics, Inc. (ITOS): Officer, Chief Executive Officer
Detheux Michel
CIK: 0001816196
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (34 total)
- Jun 11, 2026VOR
Vor Biopharma Inc.
AwardDirectStock option (right to buy)
57.2K shares- - Aug 29, 2025ITOS
iTeos Therapeutics, Inc.
DispositionIndirectStock Option (Right to Buy)
52.7K shares- - Aug 29, 2025ITOS
iTeos Therapeutics, Inc.
Tender OfferIndirect94K shares- - Aug 29, 2025ITOS
iTeos Therapeutics, Inc.
DispositionDirectStock Option (Right to Buy)
17.5K shares- - Aug 29, 2025ITOS
iTeos Therapeutics, Inc.
Tender OfferDirect153.9K shares- - Aug 29, 2025ITOS
iTeos Therapeutics, Inc.
DispositionDirectStock Option (Right to Buy)
14.2K shares- - Aug 29, 2025ITOS
iTeos Therapeutics, Inc.
DispositionDirectStock Option (Right to Buy)
94.3K shares- - Aug 29, 2025ITOS
iTeos Therapeutics, Inc.
DispositionDirectStock Option (Right to Buy)
444.8K shares- - Aug 29, 2025ITOS
iTeos Therapeutics, Inc.
DispositionDirectStock Option (Right to Buy)
50.1K shares- - Aug 29, 2025ITOS
iTeos Therapeutics, Inc.
DispositionIndirectStock Option (Right to Buy)
185K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 11, 2026 |  VOR Vor Biopharma Inc. | Award Stock option (right to buy) | 57,162 | - | - | Direct |
| Aug 29, 2025 |  ITOS iTeos Therapeutics, Inc. | Disposition Stock Option (Right to Buy) | 52,700 | - | - | Indirect |
| Aug 29, 2025 | ITOS iTeos Therapeutics, Inc. | Tender Offer | 94,027 | - | - | Indirect |
| Aug 29, 2025 | ITOS iTeos Therapeutics, Inc. | Disposition Stock Option (Right to Buy) | 17,544 | - | - | Direct |
| Aug 29, 2025 | ITOS iTeos Therapeutics, Inc. | Tender Offer | 153,903 | - | - | Direct |
| Aug 29, 2025 | ITOS iTeos Therapeutics, Inc. | Disposition Stock Option (Right to Buy) | 14,185 | - | - | Direct |
| Aug 29, 2025 | ITOS iTeos Therapeutics, Inc. | Disposition Stock Option (Right to Buy) | 94,336 | - | - | Direct |
| Aug 29, 2025 | ITOS iTeos Therapeutics, Inc. | Disposition Stock Option (Right to Buy) | 444,815 | - | - | Direct |
| Aug 29, 2025 | ITOS iTeos Therapeutics, Inc. | Disposition Stock Option (Right to Buy) | 50,128 | - | - | Direct |
| Aug 29, 2025 | ITOS iTeos Therapeutics, Inc. | Disposition Stock Option (Right to Buy) | 185,000 | - | - | Indirect |
1-10 of 34 transactions